Thursday’s Highlights at Noon: Aeterna Zentaris (AEZS), Anthera Pharmaceuticals (ANTH), Fuelcell Energy (FCEL), Medical Marijuana Inc (MJNA), NovaBay Pharma (NBY)

By Carrie Williams

So far Thursday, June 13, NASDAQ is up 0.05% and the S&P is up 0.15%. Here are this morning’s most active stocks: Aeterna Zentaris (AEZSResearch Report), Anthera Pharmaceuticals (ANTHResearch Report), Fuelcell Energy (FCELResearch Report), Medical Marijuana Inc (MJNAResearch Report) and NovaBay Pharma (NBYResearch Report).

Aeterna Zentaris is up 21.55% in midday trading to $2.82. Shares opened today at $2.32. The company has a 52-week low of $1.29 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $5.50, marking a 137.07% potential upside from current levels. In a report issued on May 21, H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on AEZS, with a price target of $5.50, which implies an upside of 137% from current levels.

Anthera Pharmaceuticals is up 16.18% in midday trading to $0.06. Shares opened today at $0.06. The company has a 52-week low of $0.01 and a 52-week high of $0.00.

Fuelcell Energy is down -14.87% in midday trading to $0.40. Shares opened today at $0.47. The company has a 52-week low of $0.20 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.00, marking a 112.77% potential upside from current levels. In a report issued on June 6, Oppenheimer analyst Colin Rusch downgraded FCEL to Hold.

See today’s analyst top recommended stocks >>

Medical Marijuana Inc is down -13.64% in midday trading to $0.06. Shares opened today at $0.06. The company has a 52-week low of $0.04 and a 52-week high of $0.00.

NovaBay Pharma is up 9.63% in midday trading to $2.05. Shares opened today at $1.87. The company has a 52-week low of $0.23 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.00, marking a -46.52% potential downside from current levels. In a report issued on March 29, H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on NBY, with a price target of $1, which reflects a potential downside of -47% from last closing price. In the last 30 days, insiders have sold $160.8K worth of NBY shares.

See today’s analyst top recommended stocks >>

Trending Stocks Based on Insider Activity >>